# S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

> **NCT00003549** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 80 (actual)

## Conditions studied

- Neuroendocrine Carcinoma of the Skin

## Interventions

- **DRUG:** CMF regimen
- **DRUG:** cyclophosphamide
- **DRUG:** fluorouracil
- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT00003549
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 2001-09
- **Final completion:** 2003-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003549, "S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00003549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*